WHO, What, When, Where, and Why: New Classification Systems for Acute Myeloid Leukemia and Their Impact on Clinical Practice

Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia

(2023) Brunangelo Falini et al.   AMERICAN JOURNAL OF HEMATOLOGY

Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management

(2023) Shai Shimony et al.   AMERICAN JOURNAL OF HEMATOLOGY

MOLECULAR CHARACTERIZATION OF MUTANT TP53 ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME

(2022) Tim Grob et al.   BLOOD

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

(2022) Olga K Weinberg et al.   Blood Advances

Developing a Classification of Hematologic Neoplasms in the Era of Precision Medicine

(2022) Mario Cazzola et al.   BLOOD

Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel

(2022) Hartmut Döhner et al.   BLOOD

International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data

(2022) Daniel A. Arber et al.   BLOOD

The WHO Classification of Haematolymphoid Tumours

(2022) Ian A. Cree   LEUKEMIA

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

(2022) Joseph D. Khoury et al.   LEUKEMIA

Response to “The WHO classification of haematolymphoid tumours” (Editorial)

(2022) Steven H. Swerdlow et al.   LEUKEMIA

AML and MDS Classification According to Who 2022 and International Consensus Classification: Do We Invent a Babylonian Confusion of Languages?

(2022) Sandra Huber et al.   BLOOD

What is in a Name? Consequences of the Classification Schism in Hematopathology

(2022) Jon C. Aster   JOURNAL OF CLINICAL ONCOLOGY

CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome

(2021) Franziska Taube et al.   BLOOD

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia

(2021) Satoshi Wakita et al.   Blood Advances

Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

(2020) Nicholas J. Short et al.   JAMA Oncology

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

(2019) Linus Angenendt et al.   JOURNAL OF CLINICAL ONCOLOGY

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

(2016) Hartmut Döhner et al.   BLOOD

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

(2014) R. C. Lindsley et al.   BLOOD

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD